PharmaShell® gives Nanexa a unique position on the expansive drug delivery market.
Since its founding in 2007, Nanexa has based its operations on a coating technique called Atomic Layer Deposition (ALD). Over the years, Nanexa has utilized the ALD technology in a variety of projects, ranging from detector technology for detecting nuclear explosions to coating on medical devices. Today, Nanexa benefits from its many years of experience in ALD and focuses on PharmaShell®.
Nanexa is now a drug delivery company focused on the nanobased drug delivery platform PharmaShell®. Nanexa runs the development of PharmaShell® with its own projects and in collaborative projects with pharmaceutical companies and academia.